BeneLein Technologies, LLC -
Significantly lowers the production cost of active pharmaceutical ingredients using proprietary bioprocessing.
We target generic pharmaceutical companies and API producers that service this industry. By replacing chemically synthesized steps with bioprocesses we can achieve over 35% lower production cost, while being greener, complying with all regulatory quality standards, and protecting process IP as having a novel and unique microbe for each process:
BeneLein Technologies provides a complete range of development capability from concept - to yield improvement - to defining process parameters.
Contact us to see how we can provide competitive advantage for your manufacturing excellence.